Amedisys, a leading provider of home health, hospice and high-acuity care in the home partners with Patients Choice Laboratories to provide molecular testing to its care centers.
“Our partnership with Patient Choice Laboratories aligns seamlessly with our dedication to delivering exceptional care and optimizing patient outcomes,” added Barbara Andazola, Vice President of Clinical Practice, Strategy and Programs at Amedisys. “By incorporating molecular testing into our infection diagnosis protocols, we are empowering our care teams to provide more accurate and effective treatments, ultimately reducing the impact of infections and preventing related hospitalizations.”
Read the full release here: https://lnkd.in/gcbRhwut